ctDNA analysis of patients (pts) with unresectable hepatocellular carcinoma (uHCC) treated with lenvatinib (LEN) or sorafenib (SOR) as 1L therapy.

Evans T.R.J.Kudo, MasatoshMasatoshKudoANN-LII CHENGWyrwicz, Lucjan S.Lucjan S.WyrwiczNgan, Roger KCRoger KCNganBlanc, Jean-FrédéricJean-FrédéricBlancBaron, Ari DavidAri DavidBaronVogel, ArndtArndtVogelet al.2026-03-032026-03-032024-06-010732183Xhttps://scholars.lib.ntu.edu.tw/handle/123456789/736056falsectDNA analysis of patients (pts) with unresectable hepatocellular carcinoma (uHCC) treated with lenvatinib (LEN) or sorafenib (SOR) as 1L therapy.review article2-s2.0-105024715640